When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report

Authors

Jonathan H. Chow, Division of Critical Care Medicine
Samuel M. Galvagno, Division of Critical Care Medicine
Kenichi A. Tanaka, University of Maryland School of Medicine
Michael A. Mazzeffi, University of Maryland School of Medicine
Zackary Chancer, Division of Critical Care Medicine
Reney Henderson, University of Maryland School of Medicine
Michael T. McCurdy, University of Maryland School of Medicine

Document Type

Journal Article

Publication Date

10-1-2018

Journal

A&A practice

Volume

11

Issue

7

DOI

10.1213/XAA.0000000000000775

Abstract

Angiotensin (AT) II is an endogenous hormone that acts on venous and arterial smooth muscle to cause vasoconstriction. Recent trials have sparked great interest in its ability to be used as a vasopressor for catecholamine-refractory hypotension. Herein, we describe the successful use of AT II in a patient with a colonic perforation with septic shock refractory to conventional treatment. After AT II initiation, there was an immediate reduction in catecholamine requirement, and the patient survived.

APA Citation

Chow, J., Galvagno, S., Tanaka, K., Mazzeffi, M., Chancer, Z., Henderson, R., & McCurdy, M. (2018). When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report. A&A practice, 11 (7). http://dx.doi.org/10.1213/XAA.0000000000000775